Locations:
SearchDr. Brian Bolwell discusses a fundamental piece of the puzzle regarding the cancer moonshot initiative
Taussig Cancer Institute Chairman Brian J. Bolwell, MD, FACP, talks about the importance of preventive cancer care and why it should be a priority of the cancer moonshot.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
“Let’s fund pilot projects and demonstration projects with a goal of having all patients receive appropriate cancer screening, regardless of insurance or income status. If we do that, then fewer patients will show up in cancer centers needing newer targeted therapies to treat advanced disease in the first place,” says Dr. Bolwell.
Read his full story here.
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients